Cronos Group Inc. (CRON)
| Market Cap | 697.56M |
| Revenue (ttm) | 117.62M |
| Net Income (ttm) | 41.08M |
| Shares Out | 382.53M |
| EPS (ttm) | 0.11 |
| PE Ratio | 17.02 |
| Forward PE | 249.45 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,629,185 |
| Open | 1.810 |
| Previous Close | 1.800 |
| Day's Range | 1.780 - 1.840 |
| 52-Week Range | 1.780 - 3.140 |
| Beta | 0.94 |
| Analysts | Hold |
| Price Target | 3.00 (+63.93%) |
| Earnings Date | May 8, 2025 |
About CRON
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. The company offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. Cronos Group Inc. was founded in 2012 and is based in Stayner, Canada. [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for CRON stock is "Hold." The 12-month stock price forecast is $3.0, which is an increase of 63.93% from the latest price.
News
Cronos Stock: Win Big Or Lose All
I maintain a 'strong buy' rating for Cronos, despite regulatory headwinds, due to its strong fundamentals and potential for multibagger returns. Cronos has shown positive progress with a robust cash b...
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U....
Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna ...
Cronos Group Inc. (CRON) 37th Annual Roth Conference (Transcript)
Cronos Group Inc. (NASDAQ:CRON) 37th Annual Roth Conference March 17, 2025 4:00 PM ET Company Participants Mike Gorenstein - Chairman, President and Chief Executive Officer Conference Call Participan...
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Ch...
Cronos Reports Improved Q4-2024 Financials With Revenues From GrowCo
Cronos reported 27% increase in revenues YOY for Q4-2024. The company is now reporting revenues from its 50% ownership of GrowCo. The company reported increasing profits and free cash flow for the qua...
Top Marijuana Stocks To Know In Today's Stock Market 2025
As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader c...
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
On Thursday, Cronos Group Inc CRON reported fourth-quarter sales of $30.3 million, up from $23.92 million, missing the consensus of $34.95 million.
Cronos Group Inc. (CRON) Q4 2024 Earnings Call Transcript
Cronos Group Inc. (NASDAQ:CRON) Q4 2024 Results Conference Call February 27, 2025 8:30 AM ET Company Participants Anna Shlimak - Chief Strategy Officer Mike Gorenstein - Chairman, President and Chief...
Cronos Group Reports 2024 Fourth Quarter and Full-Year Results
Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million
Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025
TORONTO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday...
3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise
The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no f...
Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing
Cannabis stocks tend to move on speculation around potential federal reforms around pot.
Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are p...
Top Canadian Marijuana Stocks For Your 2025 Watchlist
Most marijuana stock investors are excited about the upcoming trading year. 2025 has lots of potential in various fashions that are keeping hopes high for investors and legal operators. To start there...
Cannabis sector limps into 2025 because ‘the gold rush is over'
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by ...
3 Marijuana Stocks For Your Holiday Trading
What are marijuana stock investors searching for this holiday season? For starters, some companies have recently reported strong quarterly earnings. The better a company performs, the more intriguing ...
Marijuana Industry Could Stay in Limbo Under Trump
A hands-off policy on cannabis will be a bad outcome for a business already struggling with ambiguous laws.
Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely
If controversial Republican Matt Gaetz manages to win confirmation as attorney general, his tenure at the Justice Department is expected to be positive for the cannabis industry.
Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say
A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers in the industry, as optimism around the promise of a legal market has faded.
Cronos Group Inc. (CRON) Q3 2024 Earnings Call Transcript
Cronos Group Inc. (NASDAQ:CRON) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Anna Shlimak - Chief Strategy Officer Mike Gorenstein - Chairman, President and CEO ...
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Donald Trump's presidential election victory Tuesday, the cannabis sector took a sharp downturn.
Cannabis stocks crater as Florida fails to garner needed votes for adult use
North Dakota and South Dakota also failed in their efforts to legalize cannabis for recreational use, while a medical measure passed in Nebraska.